Skip to main content
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
232.28
-7.10 (-2.97%)
Nov 15, 2024, 10:14 AM EST - Market open

Danaher Operating Metrics

Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
16.90B 17.31B 17.96B 18.68B 19.17B 19.81B 20.36B 20.88B
Recurring Revenue Growth
-11.81% -12.62% -11.81% -10.51% -18.76% -14.56% -9.95% -4.22%

Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics Revenue
9.87B 9.76B 9.73B 9.58B 9.83B 10.25B 10.58B 10.85B
Diagnostics Revenue Growth
0.41% -4.82% -8.06% -11.72% -8.72% -2.70% 2.63% 10.21%
Life Sciences Revenue
7.23B 7.15B 7.18B 7.14B 7.16B 9.23B 11.40B 13.57B
Life Sciences Revenue Growth
0.98% -22.50% -37.03% -47.38% -54.33% -40.57% -25.47% -9.27%
Biotechnology Revenue
6.65B 6.66B 6.83B 7.17B 7.64B 5.97B 4.09B 2.22B
Biotechnology Revenue Growth
-12.93% 11.52% 67.16% 222.63% - - - -

Operating Income by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics Operating Income
2.77B 2.69B 2.56B 2.41B 2.63B 2.85B 3.23B 3.44B
Diagnostics Operating Income Growth
5.25% -5.61% -20.70% -29.98% -21.29% 4.66% 25.42% 48.55%
Biotechnology Operating Income
1.53B 1.56B 1.64B 1.91B 2.19B 1.77B 1.29B 693.00M
Biotechnology Operating Income Growth
-29.87% -11.81% 27.08% 175.47% - - - -
Life Sciences Operating Income
738.00M 1.02B 1.12B 1.21B 1.37B 2.10B 2.93B 3.73B
Life Sciences Operating Income Growth
-45.97% -51.57% -61.70% -67.58% -69.19% -51.92% -32.35% -14.61%
Other Operating Income
-323.00M -358.00M -392.00M -413.00M -417.00M -377.00M -336.00M -305.00M
Environmental Operating Income
- - - - 1.19B 1.19B 1.20B 1.14B
Environmental Operating Income Growth
- - - - 12.34% 15.60% 19.20% 7.69%

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America Revenue
10.11B 10.71B 11.20B 11.59B 12.68B 13.18B 13.64B 13.97B - -
North America Revenue Growth
-20.23% -18.75% -17.84% -17.00% -6.91% 1.22% 9.47% 18.08% - -
High Growth Markets Revenue
6.88B 7.23B 7.73B 8.28B 8.74B 8.95B 9.08B 9.13B - -
High Growth Markets Revenue Growth
-21.28% -19.12% -14.85% -9.26% -5.49% -3.47% -1.46% -0.63% - -
Western Europe Revenue
5.31B 5.58B 5.96B 6.35B 6.73B 6.81B 6.79B 6.91B - -
Western Europe Revenue Growth
-21.16% -18.06% -12.16% -8.13% -2.73% -3.45% -4.76% -0.79% - -
Other Developed Markets Revenue
1.27B 1.30B 1.33B 1.38B 1.41B 1.42B 1.44B 1.47B - -
Other Developed Markets Revenue Growth
-10.53% -8.99% -7.76% -5.92% -3.15% -3.66% -2.63% -0.54% - -

Operating Expense Breakdown
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
7.77B 7.86B 8.18B 8.52B 8.68B 8.68B 8.57B 8.52B
Selling, General, and Administrative Growth
-10.43% -9.49% -4.55% 0.06% 0.65% 1.72% 1.87% 3.88%
Research and Development
1.55B 1.58B 1.61B 1.67B 1.72B 1.72B 1.73B 1.75B
Research and Development Growth
-9.78% -7.97% -7.10% -4.24% -3.92% -4.87% -3.88% 0.17%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.